Taiwan · Delayed Price · Currency is TWD Medeon Biodesign Company Description
Medeon Biodesign, Inc. researches, develops, manufactures, and sells medical devices in the United States.
The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure.
It is involved in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices.
The company was incorporated in 2012 and is based in Taipei, Taiwan.
| Country | Taiwan |
| Founded | 2012 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 39 |
| CEO | Yue-Teh Jang |
Contact Details
Address: 116, HouGang Street Taipei, 11170 Taiwan | |
| Phone | 886 2 2881 6686 |
| Website | medeonbiodesign.com |
Stock Details
| Ticker Symbol | 6499 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006499007 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yue-Teh Jang Ph.D. | Chairman of the Board and GM |
| Dr. Jenny Chen | Vice President of Finance and Business Analysis, Head of Corporate Governance and Chief Financial Officer |
| Tori Lin | Senior Manager of Finance and Business Analysis and Accounting Officer |
| Dr. Yi-Ju Chen | Executive Vice President |
| Greta Chang | Executive Vice President |